# C_2016347EN.01000401.xml

| 22.9.2016 | EN | Official Journal of the European Union | C 347/4 |
| --- | --- | --- | --- |

22.9.2016

EN

Official Journal of the European Union

C 347/4

---

Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the first half of 2015

(2016/C 347/04)

Subcommittee I on the free movement of goods

Subcommittee I on the free movement of goods

To be noted by the EEA Joint Committee

To be noted by the EEA Joint Committee

With reference to EEA Joint Committee Decision No. 74/1999 of 28 May 1999, the EEA Joint Committee is invited to note the following lists concerning marketing authorisations for medicinal products for the period 1 January-30 June 2015, at their meeting on 29 April 2016:

| Annex I | List of new marketing authorisations |
| --- | --- |
| Annex II | List of renewed marketing authorisations |
| Annex III | List of extended marketing authorisations |
| Annex IV | List of withdrawn marketing authorisations |
| Annex V | List of suspended marketing authorisations |

Annex I

List of new marketing authorisations

Annex II

List of renewed marketing authorisations

Annex III

List of extended marketing authorisations

Annex IV

List of withdrawn marketing authorisations

Annex V

List of suspended marketing authorisations

---

ANNEX I

List of new marketing authorisations

The following marketing authorisations have been granted in the EEA EFTA States during the period 1 January-30 June 2015:

| EU Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/07/423 | Vectibix | Liechtenstein | 28.2.2015 |
| EU/1/11/709 | Buccolam | Liechtenstein | 28.2.2015 |
| EU/1/11/721 | Paglitaz | Liechtenstein | 28.2.2015 |
| EU/1/11/745 | Desloratadine Actavis | Liechtenstein | 28.2.2015 |
| EU/1/12/755 | Pioglitazone Actavis | Liechtenstein | 28.2.2015 |
| EU/1/12/757 | Pioglitazone Teva | Liechtenstein | 28.2.2015 |
| EU/1/12/758 | Pioglitazone Teva Pharma | Liechtenstein | 28.2.2015 |
| EU/1/12/760 | Bronchitol | Liechtenstein | 28.2.2015 |
| EU/1/12/811 | Lyxumia | Liechtenstein | 28.2.2015 |
| EU/1/13/817 | Actelsar HCT | Liechtenstein | 28.2.2015 |
| EU/1/13/822 | Pheburane | Liechtenstein | 28.2.2015 |
| EU/1/13/830 | Stribild | Liechtenstein | 28.2.2015 |
| EU/1/13/835 | Voriconazole Accord | Liechtenstein | 28.2.2015 |
| EU/1/13/845 | Imatinib Accord | Liechtenstein | 28.2.2015 |
| EU/1/13/846 | Xtandi | Liechtenstein | 28.2.2015 |
| EU/1/13/859 | Levodopa-Carbidopa-Entacapone Sandoz | Liechtenstein | 28.2.2015 |
| EU/1/13/879 | Giotrif | Liechtenstein | 28.2.2015 |
| EU/1/13/893 | Opsumit | Liechtenstein | 28.2.2015 |
| EU/1/14/932 | Vantobra | Iceland | 17.4.2015 |
| EU/1/14/932 | Vantobra | Norway | 15.4.2015 |
| EU/1/14/936 | Nuwiq | Liechtenstein | 28.2.2015 |
| EU/1/14/952 | Sevelamer carbonate Zentiva | Iceland | 6.2.2015 |
| EU/1/14/952 | Sevelamer carbonate Zentiva | Liechtenstein | 28.2.2015 |
| EU/1/14/952 | Sevelamer carbonate Zentiva | Norway | 6.2.2015 |
| EU/1/14/953 | Tasermity | Iceland | 12.3.2015 |
| EU/1/14/953 | Tasermity | Liechtenstein | 28.2.2015 |
| EU/1/14/953 | Tasermity | Norway | 12.3.2015 |
| EU/1/14/957 | Cyramza | Iceland | 15.1.2015 |
| EU/1/14/957 | Cyramza | Liechtenstein | 28.2.2015 |
| EU/1/14/957 | Cyramza | Norway | 13.1.2015 |
| EU/1/14/959 | Lynparza | Iceland | 14.1.2015 |
| EU/1/14/959 | Lynparza | Norway | 12.1.2015 |
| EU/1/14/960 | Duavive | Iceland | 14.1.2015 |
| EU/1/14/960 | Duavive | Norway | 12.1.2015 |
| EU/1/14/969 | Scenesse | Iceland | 15.1.2015 |
| EU/1/14/969 | Scenesse | Norway | 15.1.2015 |
| EU/1/14/970 | Rixubis | Iceland | 14.1.2015 |
| EU/1/14/970 | Rixubis | Norway | 13.1.2015 |
| EU/1/14/972 | Duloxetine Lilly | Iceland | 6.1.2015 |
| EU/1/14/973 | Quinsair | Iceland | 19.4.2015 |
| EU/1/14/973 | Quinsair | Liechtenstein | 30.4.2015 |
| EU/1/14/973 | Quinsair | Norway | 15.4.2015 |
| EU/1/14/974 | Cerdelga | Iceland | 5.2.2015 |
| EU/1/14/974 | Cerdelga | Liechtenstein | 28.2.2015 |
| EU/1/14/974 | Cerdelga | Norway | 10.2.2015 |
| EU/1/14/975 | Clopidogrel ratiopharm | Liechtenstein | 28.2.2015 |
| EU/1/14/975 | Clopidogrel ratiopharm | Norway | 5.3.2015 |
| EU/1/14/975 | Clopidogrel ratiopharm | Iceland | 11.3.2015 |
| EU/1/14/976 | Zontivity | Iceland | 5.2.2015 |
| EU/1/14/976 | Zontivity | Liechtenstein | 28.2.2015 |
| EU/1/14/976 | Zontivity | Norway | 16.2.2015 |
| EU/1/14/977 | Rasagilin ratiopharm | Liechtenstein | 28.2.2015 |
| EU/1/14/977 | Rasagiline ratiopharm | Iceland | 22.1.2015 |
| EU/1/14/977 | Rasagiline ratiopharm | Norway | 9.2.2015 |
| EU/1/14/978 | Senshio | Iceland | 30.1.2015 |
| EU/1/14/978 | Senshio | Liechtenstein | 28.2.2015 |
| EU/1/14/978 | Senshio | Norway | 16.2.2015 |
| EU/1/14/979 | Ofev | Iceland | 30.1.2015 |
| EU/1/14/979 | Ofev | Liechtenstein | 28.2.2015 |
| EU/1/14/979 | Ofev | Norway | 29.1.2015 |
| EU/1/14/980 | Cosentyx | Iceland | 4.2.2015 |
| EU/1/14/980 | Cosentyx | Liechtenstein | 28.2.2015 |
| EU/1/14/980 | Cosentyx | Norway | 30.1.2015 |
| EU/1/14/981 | Otezla | Iceland | 5.2.2015 |
| EU/1/14/981 | Otezla | Liechtenstein | 28.2.2015 |
| EU/1/14/981 | Otezla | Norway | 30.1.2015 |
| EU/1/14/982 | Viekirax | Iceland | 29.1.2015 |
| EU/1/14/982 | Viekirax | Liechtenstein | 28.2.2015 |
| EU/1/14/982 | Viekirax | Norway | 20.1.2015 |
| EU/1/14/983 | Exviera | Iceland | 29.1.2015 |
| EU/1/14/983 | Exviera | Liechtenstein | 28.2.2015 |
| EU/1/14/983 | Exviera | Norway | 20.1.2015 |
| EU/1/14/984 | Xadago | Iceland | 11.3.2015 |
| EU/1/14/984 | Xadago | Liechtenstein | 28.2.2015 |
| EU/1/14/984 | Xadago | Norway | 16.3.2015 |
| EU/1/14/985 | Raplixa | Iceland | 17.4.2015 |
| EU/1/14/985 | Raplixa | Liechtenstein | 30.4.2015 |
| EU/1/14/985 | Raplixa | Norway | 10.4.2015 |
| EU/1/14/986 | Xydalba | Iceland | 11.3.2015 |
| EU/1/14/986 | Xydalba | Liechtenstein | 28.2.2015 |
| EU/1/14/986 | Xydalba | Norway | 2.3.2015 |
| EU/1/14/987 | Holoclar | Iceland | 11.3.2015 |
| EU/1/14/987 | Holoclar | Liechtenstein | 28.2.2015 |
| EU/1/14/987 | Holoclar | Norway | 26.2.2015 |
| EU/1/14/988 | Mysimba | Iceland | 19.4.2015 |
| EU/1/14/988 | Mysimba | Liechtenstein | 30.4.2015 |
| EU/1/14/988 | Mysimba | Norway | 15.4.2015 |
| EU/1/15/1000 | Jinarc | Iceland | 4.6.2015 |
| EU/1/15/1000 | Jinarc | Liechtenstein | 30.6.2015 |
| EU/1/15/1000 | Jinarc | Norway | 12.6.2015 |
| EU/1/15/1001 | Akynzeo | Iceland | 4.6.2015 |
| EU/1/15/1001 | Akynzeo | Liechtenstein | 30.6.2015 |
| EU/1/15/1001 | Akynzeo | Norway | 5.6.2015 |
| EU/1/15/1002 | Lenvima | Iceland | 15.6.2015 |
| EU/1/15/1002 | Lenvima | Liechtenstein | 30.6.2015 |
| EU/1/15/1002 | Lenvima | Norway | 15.6.2015 |
| EU/1/15/1003 | Synjardy | Iceland | 9.6.2015 |
| EU/1/15/1003 | Synjardy | Liechtenstein | 30.6.2015 |
| EU/1/15/1003 | Synjardy | Norway | 17.6.2015 |
| EU/1/15/1004 | Voriconazol Hospira | Liechtenstein | 30.6.2015 |
| EU/1/15/1004 | Voriconazole Hospira | Iceland | 4.6.2015 |
| EU/1/15/1004 | Voriconazole Hospira | Norway | 18.6.2015 |
| EU/1/15/1007 | Gardasil 9 | Liechtenstein | 30.6.2015 |
| EU/1/15/1007 | Gardasil 9 | Norway | 18.6.2015 |
| EU/1/15/1009 | Aripiprazole Zentiva | Liechtenstein | 30.6.2015 |
| EU/1/15/1010 | Duloxetine Mylan | Liechtenstein | 30.6.2015 |
| EU/1/15/1011 | Pregabalin Sandoz | Liechtenstein | 30.6.2015 |
| EU/1/15/1012 | Pregabalin Sandoz GmbH | Liechtenstein | 30.6.2015 |
| EU/1/15/1013 | Lumark | Liechtenstein | 30.6.2015 |
| EU/1/15/1014 | Opdivo | Liechtenstein | 30.6.2015 |
| EU/1/15/989 | Orbactiv | Iceland | 17.4.2015 |
| EU/1/15/989 | Orbactiv | Liechtenstein | 30.4.2015 |
| EU/1/15/989 | Orbactiv | Norway | 15.4.2015 |
| EU/1/15/990 | Ikervis | Iceland | 17.4.2015 |
| EU/1/15/990 | Ikervis | Liechtenstein | 30.4.2015 |
| EU/1/15/990 | Ikervis | Norway | 9.4.2015 |
| EU/1/15/991 | Sivextro | Iceland | 19.4.2015 |
| EU/1/15/991 | Sivextro | Liechtenstein | 30.4.2015 |
| EU/1/15/991 | Sivextro | Norway | 15.4.2015 |
| EU/1/15/992 | Saxenda | Iceland | 19.4.2015 |
| EU/1/15/992 | Saxenda | Liechtenstein | 30.4.2015 |
| EU/1/15/992 | Saxenda | Norway | 9.4.2015 |
| EU/1/15/993 | Lixiana | Liechtenstein | 30.6.2015 |
| EU/1/15/994 | Kengrexal | Iceland | 19.4.2015 |
| EU/1/15/994 | Kengrexal | Liechtenstein | 30.4.2015 |
| EU/1/15/994 | Kengrexal | Norway | 10.4.2015 |
| EU/1/15/995 | Dutrebis | Iceland | 19.4.2015 |
| EU/1/15/995 | Dutrebis | Liechtenstein | 30.4.2015 |
| EU/1/15/995 | Dutrebis | Norway | 10.4.2015 |
| EU/1/15/996 | Ristempa | Iceland | 11.5.2015 |
| EU/1/15/996 | Ristempa | Liechtenstein | 30.4.2015 |
| EU/1/15/996 | Ristempa | Norway | 13.4.2015 |
| EU/1/15/999 | Zykadia | Iceland | 4.6.2015 |
| EU/1/15/999 | Zykadia | Liechtenstein | 30.6.2015 |
| EU/1/15/999 | Zykadia | Norway | 27.5.2015 |
| EU/2/11/122 | Bluevac BTV8 | Liechtenstein | 28.2.2015 |
| EU/2/11/131 | Zulvac 1 Ovis | Liechtenstein | 28.2.2015 |
| EU/2/12/140 | Poulvac E. coli | Liechtenstein | 28.2.2015 |
| EU/2/12/142 | Cardalis | Liechtenstein | 28.2.2015 |
| EU/2/13/151 | Equilis West Nile | Liechtenstein | 28.2.2015 |
| EU/2/13/152 | ProZinc | Liechtenstein | 28.2.2015 |
| EU/2/14/162 | Parvoduk | Liechtenstein | 28.2.2015 |
| EU/2/14/176 | Bovela | Iceland | 15.1.2015 |
| EU/2/14/176 | Bovela | Norway | 23.1.2015 |
| EU/2/14/177 | Nexgard Spectra | Iceland | 30.1.2015 |
| EU/2/14/177 | Nexgard Spectra | Liechtenstein | 28.2.2015 |
| EU/2/14/177 | Nexgard Spectra | Norway | 13.2.2015 |
| EU/2/14/178 | Zulvac SBV | Iceland | 24.2.2015 |
| EU/2/14/178 | Zulvac SBV | Liechtenstein | 28.2.2015 |
| EU/2/14/178 | Zulvac SBV | Norway | 11.3.2015 |
| EU/2/14/179 | Suvaxyn CSF Marker | Iceland | 9.4.2015 |
| EU/2/14/179 | Suvaxyn CSF Marker | Liechtenstein | 30.4.2015 |
| EU/2/14/179 | Suvaxyn CSF Marker | Norway | 9.4.2015 |
| EU/2/14/180 | Coliprotec F4 | Iceland | 15.4.2015 |
| EU/2/14/180 | Coliprotec F4 | Liechtenstein | 30.4.2015 |
| EU/2/14/180 | Coliprotec F4 | Norway | 9.4.2015 |
| EU/2/15/181 | Sileo | Liechtenstein | 30.6.2015 |
| EU/2/15/181 | Sileo | Norway | 30.6.2015 |

EU Number

Product

Country

Date of authorisation

EU/1/07/423

Vectibix

Liechtenstein

28.2.2015

EU/1/11/709

Buccolam

Liechtenstein

28.2.2015

EU/1/11/721

Paglitaz

Liechtenstein

28.2.2015

EU/1/11/745

Desloratadine Actavis

Liechtenstein

28.2.2015

EU/1/12/755

Pioglitazone Actavis

Liechtenstein

28.2.2015

EU/1/12/757

Pioglitazone Teva

Liechtenstein

28.2.2015

EU/1/12/758

Pioglitazone Teva Pharma

Liechtenstein

28.2.2015

EU/1/12/760

Bronchitol

Liechtenstein

28.2.2015

EU/1/12/811

Lyxumia

Liechtenstein

28.2.2015

EU/1/13/817

Actelsar HCT

Liechtenstein

28.2.2015

EU/1/13/822

Pheburane

Liechtenstein

28.2.2015

EU/1/13/830

Stribild

Liechtenstein

28.2.2015

EU/1/13/835

Voriconazole Accord

Liechtenstein

28.2.2015

EU/1/13/845

Imatinib Accord

Liechtenstein

28.2.2015

EU/1/13/846

Xtandi

Liechtenstein

28.2.2015

EU/1/13/859

Levodopa-Carbidopa-Entacapone Sandoz

Liechtenstein

28.2.2015

EU/1/13/879

Giotrif

Liechtenstein

28.2.2015

EU/1/13/893

Opsumit

Liechtenstein

28.2.2015

EU/1/14/932

Vantobra

Iceland

17.4.2015

EU/1/14/932

Vantobra

Norway

15.4.2015

EU/1/14/936

Nuwiq

Liechtenstein

28.2.2015

EU/1/14/952

Sevelamer carbonate Zentiva

Iceland

6.2.2015

EU/1/14/952

Sevelamer carbonate Zentiva

Liechtenstein

28.2.2015

EU/1/14/952

Sevelamer carbonate Zentiva

Norway

6.2.2015

EU/1/14/953

Tasermity

Iceland

12.3.2015

EU/1/14/953

Tasermity

Liechtenstein

28.2.2015

EU/1/14/953

Tasermity

Norway

12.3.2015

EU/1/14/957

Cyramza

Iceland

15.1.2015

EU/1/14/957

Cyramza

Liechtenstein

28.2.2015

EU/1/14/957

Cyramza

Norway

13.1.2015

EU/1/14/959

Lynparza

Iceland

14.1.2015

EU/1/14/959

Lynparza

Norway

12.1.2015

EU/1/14/960

Duavive

Iceland

14.1.2015

EU/1/14/960

Duavive

Norway

12.1.2015

EU/1/14/969

Scenesse

Iceland

15.1.2015

EU/1/14/969

Scenesse

Norway

15.1.2015

EU/1/14/970

Rixubis

Iceland

14.1.2015

EU/1/14/970

Rixubis

Norway

13.1.2015

EU/1/14/972

Duloxetine Lilly

Iceland

6.1.2015

EU/1/14/973

Quinsair

Iceland

19.4.2015

EU/1/14/973

Quinsair

Liechtenstein

30.4.2015

EU/1/14/973

Quinsair

Norway

15.4.2015

EU/1/14/974

Cerdelga

Iceland

5.2.2015

EU/1/14/974

Cerdelga

Liechtenstein

28.2.2015

EU/1/14/974

Cerdelga

Norway

10.2.2015

EU/1/14/975

Clopidogrel ratiopharm

Liechtenstein

28.2.2015

EU/1/14/975

Clopidogrel ratiopharm

Norway

5.3.2015

EU/1/14/975

Clopidogrel ratiopharm

Iceland

11.3.2015

EU/1/14/976

Zontivity

Iceland

5.2.2015

EU/1/14/976

Zontivity

Liechtenstein

28.2.2015

EU/1/14/976

Zontivity

Norway

16.2.2015

EU/1/14/977

Rasagilin ratiopharm

Liechtenstein

28.2.2015

EU/1/14/977

Rasagiline ratiopharm

Iceland

22.1.2015

EU/1/14/977

Rasagiline ratiopharm

Norway

9.2.2015

EU/1/14/978

Senshio

Iceland

30.1.2015

EU/1/14/978

Senshio

Liechtenstein

28.2.2015

EU/1/14/978

Senshio

Norway

16.2.2015

EU/1/14/979

Ofev

Iceland

30.1.2015

EU/1/14/979

Ofev

Liechtenstein

28.2.2015

EU/1/14/979

Ofev

Norway

29.1.2015

EU/1/14/980

Cosentyx

Iceland

4.2.2015

EU/1/14/980

Cosentyx

Liechtenstein

28.2.2015

EU/1/14/980

Cosentyx

Norway

30.1.2015

EU/1/14/981

Otezla

Iceland

5.2.2015

EU/1/14/981

Otezla

Liechtenstein

28.2.2015

EU/1/14/981

Otezla

Norway

30.1.2015

EU/1/14/982

Viekirax

Iceland

29.1.2015

EU/1/14/982

Viekirax

Liechtenstein

28.2.2015

EU/1/14/982

Viekirax

Norway

20.1.2015

EU/1/14/983

Exviera

Iceland

29.1.2015

EU/1/14/983

Exviera

Liechtenstein

28.2.2015

EU/1/14/983

Exviera

Norway

20.1.2015

EU/1/14/984

Xadago

Iceland

11.3.2015

EU/1/14/984

Xadago

Liechtenstein

28.2.2015

EU/1/14/984

Xadago

Norway

16.3.2015

EU/1/14/985

Raplixa

Iceland

17.4.2015

EU/1/14/985

Raplixa

Liechtenstein

30.4.2015

EU/1/14/985

Raplixa

Norway

10.4.2015

EU/1/14/986

Xydalba

Iceland

11.3.2015

EU/1/14/986

Xydalba

Liechtenstein

28.2.2015

EU/1/14/986

Xydalba

Norway

2.3.2015

EU/1/14/987

Holoclar

Iceland

11.3.2015

EU/1/14/987

Holoclar

Liechtenstein

28.2.2015

EU/1/14/987

Holoclar

Norway

26.2.2015

EU/1/14/988

Mysimba

Iceland

19.4.2015

EU/1/14/988

Mysimba

Liechtenstein

30.4.2015

EU/1/14/988

Mysimba

Norway

15.4.2015

EU/1/15/1000

Jinarc

Iceland

4.6.2015

EU/1/15/1000

Jinarc

Liechtenstein

30.6.2015

EU/1/15/1000

Jinarc

Norway

12.6.2015

EU/1/15/1001

Akynzeo

Iceland

4.6.2015

EU/1/15/1001

Akynzeo

Liechtenstein

30.6.2015

EU/1/15/1001

Akynzeo

Norway

5.6.2015

EU/1/15/1002

Lenvima

Iceland

15.6.2015

EU/1/15/1002

Lenvima

Liechtenstein

30.6.2015

EU/1/15/1002

Lenvima

Norway

15.6.2015

EU/1/15/1003

Synjardy

Iceland

9.6.2015

EU/1/15/1003

Synjardy

Liechtenstein

30.6.2015

EU/1/15/1003

Synjardy

Norway

17.6.2015

EU/1/15/1004

Voriconazol Hospira

Liechtenstein

30.6.2015

EU/1/15/1004

Voriconazole Hospira

Iceland

4.6.2015

EU/1/15/1004

Voriconazole Hospira

Norway

18.6.2015

EU/1/15/1007

Gardasil 9

Liechtenstein

30.6.2015

EU/1/15/1007

Gardasil 9

Norway

18.6.2015

EU/1/15/1009

Aripiprazole Zentiva

Liechtenstein

30.6.2015

EU/1/15/1010

Duloxetine Mylan

Liechtenstein

30.6.2015

EU/1/15/1011

Pregabalin Sandoz

Liechtenstein

30.6.2015

EU/1/15/1012

Pregabalin Sandoz GmbH

Liechtenstein

30.6.2015

EU/1/15/1013

Lumark

Liechtenstein

30.6.2015

EU/1/15/1014

Opdivo

Liechtenstein

30.6.2015

EU/1/15/989

Orbactiv

Iceland

17.4.2015

EU/1/15/989

Orbactiv

Liechtenstein

30.4.2015

EU/1/15/989

Orbactiv

Norway

15.4.2015

EU/1/15/990

Ikervis

Iceland

17.4.2015

EU/1/15/990

Ikervis

Liechtenstein

30.4.2015

EU/1/15/990

Ikervis

Norway

9.4.2015

EU/1/15/991

Sivextro

Iceland

19.4.2015

EU/1/15/991

Sivextro

Liechtenstein

30.4.2015

EU/1/15/991

Sivextro

Norway

15.4.2015

EU/1/15/992

Saxenda

Iceland

19.4.2015

EU/1/15/992

Saxenda

Liechtenstein

30.4.2015

EU/1/15/992

Saxenda

Norway

9.4.2015

EU/1/15/993

Lixiana

Liechtenstein

30.6.2015

EU/1/15/994

Kengrexal

Iceland

19.4.2015

EU/1/15/994

Kengrexal

Liechtenstein

30.4.2015

EU/1/15/994

Kengrexal

Norway

10.4.2015

EU/1/15/995

Dutrebis

Iceland

19.4.2015

EU/1/15/995

Dutrebis

Liechtenstein

30.4.2015

EU/1/15/995

Dutrebis

Norway

10.4.2015

EU/1/15/996

Ristempa

Iceland

11.5.2015

EU/1/15/996

Ristempa

Liechtenstein

30.4.2015

EU/1/15/996

Ristempa

Norway

13.4.2015

EU/1/15/999

Zykadia

Iceland

4.6.2015

EU/1/15/999

Zykadia

Liechtenstein

30.6.2015

EU/1/15/999

Zykadia

Norway

27.5.2015

EU/2/11/122

Bluevac BTV8

Liechtenstein

28.2.2015

EU/2/11/131

Zulvac 1 Ovis

Liechtenstein

28.2.2015

EU/2/12/140

Poulvac E. coli

Liechtenstein

28.2.2015

EU/2/12/142

Cardalis

Liechtenstein

28.2.2015

EU/2/13/151

Equilis West Nile

Liechtenstein

28.2.2015

EU/2/13/152

ProZinc

Liechtenstein

28.2.2015

EU/2/14/162

Parvoduk

Liechtenstein

28.2.2015

EU/2/14/176

Bovela

Iceland

15.1.2015

EU/2/14/176

Bovela

Norway

23.1.2015

EU/2/14/177

Nexgard Spectra

Iceland

30.1.2015

EU/2/14/177

Nexgard Spectra

Liechtenstein

28.2.2015

EU/2/14/177

Nexgard Spectra

Norway

13.2.2015

EU/2/14/178

Zulvac SBV

Iceland

24.2.2015

EU/2/14/178

Zulvac SBV

Liechtenstein

28.2.2015

EU/2/14/178

Zulvac SBV

Norway

11.3.2015

EU/2/14/179

Suvaxyn CSF Marker

Iceland

9.4.2015

EU/2/14/179

Suvaxyn CSF Marker

Liechtenstein

30.4.2015

EU/2/14/179

Suvaxyn CSF Marker

Norway

9.4.2015

EU/2/14/180

Coliprotec F4

Iceland

15.4.2015

EU/2/14/180

Coliprotec F4

Liechtenstein

30.4.2015

EU/2/14/180

Coliprotec F4

Norway

9.4.2015

EU/2/15/181

Sileo

Liechtenstein

30.6.2015

EU/2/15/181

Sileo

Norway

30.6.2015

---

ANNEX II

List of renewed marketing authorisations

The following marketing authorisations have been renewed in the EEA EFTA States during the period 1 January-30 June 2015:

| EU Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/00/133 | Optisulin | Iceland | 18.3.2015 |
| EU/1/00/133 | Optisulin | Liechtenstein | 28.2.2015 |
| EU/1/00/133 | Optisulin | Norway | 27.2.2015 |
| EU/1/00/134 | Lantus | Iceland | 17.3.2015 |
| EU/1/00/134 | Lantus | Liechtenstein | 28.2.2015 |
| EU/1/00/134 | Lantus | Norway | 5.3.2015 |
| EU/1/05/308 | Aclasta | Iceland | 5.2.2015 |
| EU/1/05/308 | Aclasta | Liechtenstein | 28.2.2015 |
| EU/1/05/308 | Aclasta | Norway | 17.2.2015 |
| EU/1/05/310 | Fosavance | Liechtenstein | 30.6.2015 |
| EU/1/05/310 | Fosavance | Norway | 19.5.2015 |
| EU/1/05/315 | Aptivus | Liechtenstein | 30.6.2015 |
| EU/1/05/319 | Xolair | Liechtenstein | 30.6.2015 |
| EU/1/07/423 | Vectibix | Iceland | 15.1.2015 |
| EU/1/07/423 | Vectibix | Norway | 29.1.2015 |
| EU/1/08/506 | Celvapan | Iceland | 3.6.2015 |
| EU/1/08/506 | Celvapan | Liechtenstein | 30.6.2015 |
| EU/1/08/506 | Celvapan | Norway | 27.5.2015 |
| EU/1/09/601 | Firdapse | Iceland | 18.2.2015 |
| EU/1/09/610 | Telmisartan Teva | Iceland | 14.1.2015 |
| EU/1/09/610 | Telmisartan Teva | Liechtenstein | 28.2.2015 |
| EU/1/09/610 | Telmisartan Teva | Norway | 13.1.2015 |
| EU/1/10/612 | Revolade | Iceland | 30.1.2015 |
| EU/1/10/612 | Revolade | Liechtenstein | 28.2.2015 |
| EU/1/10/612 | Revolade | Norway | 29.1.2015 |
| EU/1/10/615 | Temozolomide Hospira | Iceland | 22.1.2015 |
| EU/1/10/615 | Temozolomide Hospira | Liechtenstein | 28.2.2015 |
| EU/1/10/615 | Temozolomide Hospira | Norway | 28.1.2015 |
| EU/1/10/618 | Prolia | Iceland | 4.2.2015 |
| EU/1/10/618 | Prolia | Liechtenstein | 28.2.2015 |
| EU/1/10/618 | Prolia | Norway | 9.2.2015 |
| EU/1/10/620 | Ristfor | Iceland | 14.1.2015 |
| EU/1/10/620 | Ristfor | Norway | 13.1.2015 |
| EU/1/10/621 | Ristaben | Iceland | 14.1.2015 |
| EU/1/10/621 | Ristaben | Norway | 13.1.2015 |
| EU/1/10/625 | Arzerra | Iceland | 2.3.2015 |
| EU/1/10/625 | Arzerra | Liechtenstein | 28.2.2015 |
| EU/1/10/625 | Arzerra | Norway | 26.2.2015 |
| EU/1/10/627 | Raloxifene Teva | Iceland | 20.2.2015 |
| EU/1/10/627 | Raloxifene Teva | Liechtenstein | 28.2.2015 |
| EU/1/10/627 | Raloxifene Teva | Norway | 27.2.2015 |
| EU/1/10/631 | Nivestim | Iceland | 15.6.2015 |
| EU/1/10/631 | Nivestim | Liechtenstein | 30.6.2015 |
| EU/1/10/631 | Nivestim | Norway | 18.6.2015 |
| EU/1/10/632 | Tolura | Iceland | 17.4.2015 |
| EU/1/10/632 | Tolura | Liechtenstein | 30.4.2015 |
| EU/1/10/632 | Tolura | Norway | 9.4.2015 |
| EU/1/10/633 | Topotecan Hospira | Iceland | 15.6.2015 |
| EU/1/10/633 | Topotecan Hospira | Liechtenstein | 30.6.2015 |
| EU/1/10/633 | Topotecan Hospira | Norway | 15.6.2015 |
| EU/1/10/634 | Ribavirin Mylan | Liechtenstein | 28.2.2015 |
| EU/1/10/634 | Ribavirin Mylan | Norway | 27.2.2015 |
| EU/1/10/634 | Ribavirin Mylan | Iceland | 20.2.2015 |
| EU/1/10/635 | Olanzapin Apotex | Liechtenstein | 28.2.2015 |
| EU/1/10/635 | Olanzapin Apotex | Norway | 27.2.2015 |
| EU/1/10/635 | Olanzapine Apotex | Iceland | 20.2.2015 |
| EU/1/10/636 | Daxas | Iceland | 12.5.2015 |
| EU/1/10/636 | Daxas | Norway | 15.5.2015 |
| EU/1/10/637 | Leflunomid medac | Liechtenstein | 30.4.2015 |
| EU/1/10/637 | Leflunomide medac | Iceland | 19.4.2015 |
| EU/1/10/637 | Leflunomide medac | Norway | 9.4.2015 |
| EU/1/10/638 | Ozurdex | Iceland | 19.4.2015 |
| EU/1/10/638 | Ozurdex | Liechtenstein | 30.4.2015 |
| EU/1/10/638 | Ozurdex | Norway | 9.4.2015 |
| EU/1/10/639 | Telmisartan Actavis | Liechtenstein | 30.6.2015 |
| EU/1/10/640 | Sycrest | Iceland | 1.6.2015 |
| EU/1/10/640 | Sycrest | Liechtenstein | 30.6.2015 |
| EU/1/10/640 | Sycrest | Norway | 3.6.2015 |
| EU/1/10/642 | Ibandronsäure Teva | Liechtenstein | 30.6.2015 |
| EU/1/10/643 | Rapiscan | Iceland | 12.5.2015 |
| EU/1/10/643 | Rapiscan | Liechtenstein | 30.6.2015 |
| EU/1/10/643 | Rapiscan | Norway | 15.6.2015 |
| EU/1/10/646 | VPRIV | Liechtenstein | 30.6.2015 |
| EU/1/10/647 | Myclausen | Iceland | 9.6.2015 |
| EU/1/10/647 | Myclausen | Liechtenstein | 30.6.2015 |
| EU/1/10/647 | Myclausen | Norway | 15.6.2015 |
| EU/1/10/651 | Clopidogrel HCS | Liechtenstein | 30.6.2015 |
| EU/1/10/654 | Leflunomid ratiopharm | Liechtenstein | 30.6.2015 |
| EU/1/11/666 | Libertek | Iceland | 12.5.2015 |
| EU/1/11/666 | Libertek | Liechtenstein | 30.6.2015 |
| EU/1/11/666 | Libertek | Norway | 15.5.2015 |
| EU/1/11/668 | Daliresp | Iceland | 12.5.2015 |
| EU/1/11/668 | Daliresp | Liechtenstein | 30.6.2015 |
| EU/1/11/668 | Daliresp | Norway | 15.5.2015 |
| EU/1/11/749 | Caprelsa | Iceland | 30.1.2015 |
| EU/1/11/749 | Caprelsa | Liechtenstein | 28.2.2015 |
| EU/1/11/749 | Caprelsa | Norway | 29.1.2015 |
| EU/1/12/764 | Pixuvri | Iceland | 19.4.2015 |
| EU/1/12/764 | Pixuvri | Norway | 9.4.2015 |
| EU/1/13/818 | Bosulif | Iceland | 11.3.2015 |
| EU/1/13/818 | Bosulif | Liechtenstein | 28.2.2015 |
| EU/1/13/818 | Bosulif | Norway | 6.3.2015 |
| EU/1/13/848 | Erivedge | Iceland | 5.6.2015 |
| EU/1/13/848 | Erivedge | Liechtenstein | 30.6.2015 |
| EU/1/13/848 | Erivedge | Norway | 15.6.2015 |
| EU/1/13/875 | Deltyba | Iceland | 12.5.2015 |
| EU/1/13/875 | Deltyba | Liechtenstein | 30.6.2015 |
| EU/1/13/875 | Deltyba | Norway | 15.5.2015 |
| EU/1/13/890 | Cometriq | Iceland | 5.2.2015 |
| EU/1/13/890 | Cometriq | Liechtenstein | 28.2.2015 |
| EU/1/13/890 | Cometriq | Norway | 13.2.2015 |
| EU/1/13/901 | Sirturo | Iceland | 5.2.2015 |
| EU/1/13/901 | Sirturo | Liechtenstein | 28.2.2015 |
| EU/1/13/901 | Sirturo | Norway | 10.2.2015 |
| EU/2/05/055 | Equilis Te | Liechtenstein | 30.6.2015 |
| EU/2/05/055 | Equilis Te | Norway | 30.6.2015 |
| EU/2/09/103 | Respiporc Flu3 | Norway | 16.1.2015 |
| EU/2/09/104 | Zulvac 8 Ovis | Norway | 14.1.2015 |
| EU/2/10/106 | Bovilis BTV8 | Iceland | 16.6.2015 |
| EU/2/10/106 | Bovilis BTV8 | Liechtenstein | 30.6.2015 |
| EU/2/10/106 | Bovilis BTV8 | Norway | 26.6.2015 |
| EU/2/10/109 | Rhiniseng | Liechtenstein | 30.6.2015 |

EU Number

Product

Country

Date of authorisation

EU/1/00/133

Optisulin

Iceland

18.3.2015

EU/1/00/133

Optisulin

Liechtenstein

28.2.2015

EU/1/00/133

Optisulin

Norway

27.2.2015

EU/1/00/134

Lantus

Iceland

17.3.2015

EU/1/00/134

Lantus

Liechtenstein

28.2.2015

EU/1/00/134

Lantus

Norway

5.3.2015

EU/1/05/308

Aclasta

Iceland

5.2.2015

EU/1/05/308

Aclasta

Liechtenstein

28.2.2015

EU/1/05/308

Aclasta

Norway

17.2.2015

EU/1/05/310

Fosavance

Liechtenstein

30.6.2015

EU/1/05/310

Fosavance

Norway

19.5.2015

EU/1/05/315

Aptivus

Liechtenstein

30.6.2015

EU/1/05/319

Xolair

Liechtenstein

30.6.2015

EU/1/07/423

Vectibix

Iceland

15.1.2015

EU/1/07/423

Vectibix

Norway

29.1.2015

EU/1/08/506

Celvapan

Iceland

3.6.2015

EU/1/08/506

Celvapan

Liechtenstein

30.6.2015

EU/1/08/506

Celvapan

Norway

27.5.2015

EU/1/09/601

Firdapse

Iceland

18.2.2015

EU/1/09/610

Telmisartan Teva

Iceland

14.1.2015

EU/1/09/610

Telmisartan Teva

Liechtenstein

28.2.2015

EU/1/09/610

Telmisartan Teva

Norway

13.1.2015

EU/1/10/612

Revolade

Iceland

30.1.2015

EU/1/10/612

Revolade

Liechtenstein

28.2.2015

EU/1/10/612

Revolade

Norway

29.1.2015

EU/1/10/615

Temozolomide Hospira

Iceland

22.1.2015

EU/1/10/615

Temozolomide Hospira

Liechtenstein

28.2.2015

EU/1/10/615

Temozolomide Hospira

Norway

28.1.2015

EU/1/10/618

Prolia

Iceland

4.2.2015

EU/1/10/618

Prolia

Liechtenstein

28.2.2015

EU/1/10/618

Prolia

Norway

9.2.2015

EU/1/10/620

Ristfor

Iceland

14.1.2015

EU/1/10/620

Ristfor

Norway

13.1.2015

EU/1/10/621

Ristaben

Iceland

14.1.2015

EU/1/10/621

Ristaben

Norway

13.1.2015

EU/1/10/625

Arzerra

Iceland

2.3.2015

EU/1/10/625

Arzerra

Liechtenstein

28.2.2015

EU/1/10/625

Arzerra

Norway

26.2.2015

EU/1/10/627

Raloxifene Teva

Iceland

20.2.2015

EU/1/10/627

Raloxifene Teva

Liechtenstein

28.2.2015

EU/1/10/627

Raloxifene Teva

Norway

27.2.2015

EU/1/10/631

Nivestim

Iceland

15.6.2015

EU/1/10/631

Nivestim

Liechtenstein

30.6.2015

EU/1/10/631

Nivestim

Norway

18.6.2015

EU/1/10/632

Tolura

Iceland

17.4.2015

EU/1/10/632

Tolura

Liechtenstein

30.4.2015

EU/1/10/632

Tolura

Norway

9.4.2015

EU/1/10/633

Topotecan Hospira

Iceland

15.6.2015

EU/1/10/633

Topotecan Hospira

Liechtenstein

30.6.2015

EU/1/10/633

Topotecan Hospira

Norway

15.6.2015

EU/1/10/634

Ribavirin Mylan

Liechtenstein

28.2.2015

EU/1/10/634

Ribavirin Mylan

Norway

27.2.2015

EU/1/10/634

Ribavirin Mylan

Iceland

20.2.2015

EU/1/10/635

Olanzapin Apotex

Liechtenstein

28.2.2015

EU/1/10/635

Olanzapin Apotex

Norway

27.2.2015

EU/1/10/635

Olanzapine Apotex

Iceland

20.2.2015

EU/1/10/636

Daxas

Iceland

12.5.2015

EU/1/10/636

Daxas

Norway

15.5.2015

EU/1/10/637

Leflunomid medac

Liechtenstein

30.4.2015

EU/1/10/637

Leflunomide medac

Iceland

19.4.2015

EU/1/10/637

Leflunomide medac

Norway

9.4.2015

EU/1/10/638

Ozurdex

Iceland

19.4.2015

EU/1/10/638

Ozurdex

Liechtenstein

30.4.2015

EU/1/10/638

Ozurdex

Norway

9.4.2015

EU/1/10/639

Telmisartan Actavis

Liechtenstein

30.6.2015

EU/1/10/640

Sycrest

Iceland

1.6.2015

EU/1/10/640

Sycrest

Liechtenstein

30.6.2015

EU/1/10/640

Sycrest

Norway

3.6.2015

EU/1/10/642

Ibandronsäure Teva

Liechtenstein

30.6.2015

EU/1/10/643

Rapiscan

Iceland

12.5.2015

EU/1/10/643

Rapiscan

Liechtenstein

30.6.2015

EU/1/10/643

Rapiscan

Norway

15.6.2015

EU/1/10/646

VPRIV

Liechtenstein

30.6.2015

EU/1/10/647

Myclausen

Iceland

9.6.2015

EU/1/10/647

Myclausen

Liechtenstein

30.6.2015

EU/1/10/647

Myclausen

Norway

15.6.2015

EU/1/10/651

Clopidogrel HCS

Liechtenstein

30.6.2015

EU/1/10/654

Leflunomid ratiopharm

Liechtenstein

30.6.2015

EU/1/11/666

Libertek

Iceland

12.5.2015

EU/1/11/666

Libertek

Liechtenstein

30.6.2015

EU/1/11/666

Libertek

Norway

15.5.2015

EU/1/11/668

Daliresp

Iceland

12.5.2015

EU/1/11/668

Daliresp

Liechtenstein

30.6.2015

EU/1/11/668

Daliresp

Norway

15.5.2015

EU/1/11/749

Caprelsa

Iceland

30.1.2015

EU/1/11/749

Caprelsa

Liechtenstein

28.2.2015

EU/1/11/749

Caprelsa

Norway

29.1.2015

EU/1/12/764

Pixuvri

Iceland

19.4.2015

EU/1/12/764

Pixuvri

Norway

9.4.2015

EU/1/13/818

Bosulif

Iceland

11.3.2015

EU/1/13/818

Bosulif

Liechtenstein

28.2.2015

EU/1/13/818

Bosulif

Norway

6.3.2015

EU/1/13/848

Erivedge

Iceland

5.6.2015

EU/1/13/848

Erivedge

Liechtenstein

30.6.2015

EU/1/13/848

Erivedge

Norway

15.6.2015

EU/1/13/875

Deltyba

Iceland

12.5.2015

EU/1/13/875

Deltyba

Liechtenstein

30.6.2015

EU/1/13/875

Deltyba

Norway

15.5.2015

EU/1/13/890

Cometriq

Iceland

5.2.2015

EU/1/13/890

Cometriq

Liechtenstein

28.2.2015

EU/1/13/890

Cometriq

Norway

13.2.2015

EU/1/13/901

Sirturo

Iceland

5.2.2015

EU/1/13/901

Sirturo

Liechtenstein

28.2.2015

EU/1/13/901

Sirturo

Norway

10.2.2015

EU/2/05/055

Equilis Te

Liechtenstein

30.6.2015

EU/2/05/055

Equilis Te

Norway

30.6.2015

EU/2/09/103

Respiporc Flu3

Norway

16.1.2015

EU/2/09/104

Zulvac 8 Ovis

Norway

14.1.2015

EU/2/10/106

Bovilis BTV8

Iceland

16.6.2015

EU/2/10/106

Bovilis BTV8

Liechtenstein

30.6.2015

EU/2/10/106

Bovilis BTV8

Norway

26.6.2015

EU/2/10/109

Rhiniseng

Liechtenstein

30.6.2015

---

ANNEX III

List of extended marketing authorisations

The following marketing authorisations have been extended in the EEA EFTA States during the period 1 January-30 June 2015:

| EU Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/00/133/033-035 | Toujeo | Iceland | 12.5.2015 |
| EU/1/00/133/033-035 | Toujeo | Norway | 19.5.2015 |
| EU/1/01/195/028-029 | Liprolog KwikPen | Iceland | 19.2.2015 |
| EU/1/04/303/004 | Orfadin | Iceland | 3.6.2015 |
| EU/1/04/303/004 | Orfadin | Norway | 28.5.2015 |
| EU/1/07/319/009 | Revlimid | Norway | 2.3.2015 |
| EU/1/07/391/009 | Revlimid | Iceland | 10.3.2015 |
| EU/1/08/469/046-049 | Oprymea | Iceland | 2.3.2015 |
| EU/1/08/469/050-053 | Oprymea | Iceland | 2.3.2015 |
| EU/1/08/469/046-049 | Oprymea | Norway | 25.2.2015 |
| EU/1/08/469/050-053 | Oprymea | Norway | 25.2.2015 |
| EU/1/12/771/007-009 | Zoledronic Acid Teva | Iceland | 15.1.2015 |
| EU/1/12/798/005-006 | Ibandronic acid Accord | Iceland | 19.4.2015 |
| EU/1/12/798/005-006 | Ibandronic acid Accord | Norway | 10.4.2015 |
| EU/1/13/819/002 | Jetrea | Iceland | 13.5.2015 |
| EU/1/13/819/002 | Jetrea | Norway | 13.5.2015 |
| EU/1/96/007/039-042 | Humalog KwikPen | Iceland | 19.2.2015 |
| EU/2/06/062/005 | Cerenia | Norway | 29.6.2015 |
| EU/2/07/078/021 | Rheumocam | Iceland | 4.6.2015 |
| EU/2/07/078/021 | Rheumocam | Norway | 2.6.2015 |
| EU/2/97/004/050-053 | Metacam | Norway | 6.5.2015 |
| EU/2/97/004/050-053 | Metacam | Iceland | 6.5.2015 |
| EU/2/99/014/013-016 | Stronghold | Norway | 10.4.2015 |

EU Number

Product

Country

Date of authorisation

EU/1/00/133/033-035

Toujeo

Iceland

12.5.2015

EU/1/00/133/033-035

Toujeo

Norway

19.5.2015

EU/1/01/195/028-029

Liprolog KwikPen

Iceland

19.2.2015

EU/1/04/303/004

Orfadin

Iceland

3.6.2015

EU/1/04/303/004

Orfadin

Norway

28.5.2015

EU/1/07/319/009

Revlimid

Norway

2.3.2015

EU/1/07/391/009

Revlimid

Iceland

10.3.2015

EU/1/08/469/046-049

Oprymea

Iceland

2.3.2015

EU/1/08/469/050-053

Oprymea

Iceland

2.3.2015

EU/1/08/469/046-049

Oprymea

Norway

25.2.2015

EU/1/08/469/050-053

Oprymea

Norway

25.2.2015

EU/1/12/771/007-009

Zoledronic Acid Teva

Iceland

15.1.2015

EU/1/12/798/005-006

Ibandronic acid Accord

Iceland

19.4.2015

EU/1/12/798/005-006

Ibandronic acid Accord

Norway

10.4.2015

EU/1/13/819/002

Jetrea

Iceland

13.5.2015

EU/1/13/819/002

Jetrea

Norway

13.5.2015

EU/1/96/007/039-042

Humalog KwikPen

Iceland

19.2.2015

EU/2/06/062/005

Cerenia

Norway

29.6.2015

EU/2/07/078/021

Rheumocam

Iceland

4.6.2015

EU/2/07/078/021

Rheumocam

Norway

2.6.2015

EU/2/97/004/050-053

Metacam

Norway

6.5.2015

EU/2/97/004/050-053

Metacam

Iceland

6.5.2015

EU/2/99/014/013-016

Stronghold

Norway

10.4.2015

---

ANNEX IV

List of withdrawn marketing authorisations

The following marketing authorisations have been withdrawn in the EEA EFTA States during the period 1 January-30 June 2015:

| EU Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/07/426 | Olanzapine Cipla | Norway | 21.1.2015 |
| EU/1/08/458 | Trevaclyn | Liechtenstein | 28.2.2015 |
| EU/1/08/459 | Tredaptive | Liechtenstein | 28.2.2015 |
| EU/1/08/460 | Pelzont | Liechtenstein | 28.2.2015 |
| EU/1/09/554 | Clopidogrel ratiopharm | Liechtenstein | 28.2.2015 |
| EU/1/09/560 | Clopidogrel Dura | Liechtenstein | 30.6.2015 |
| EU/1/09/560 | Clopidogrel Dura | Norway | 30.6.2015 |
| EU/1/10/649 | Clopidogrel Teva Pharma B.V. | Norway | 21.1.2015 |
| EU/1/10/650 | Clopidogrel Teva Generics B.V. | Iceland | 5.2.2015 |
| EU/1/10/664 | Pumarix | Iceland | 20.2.2015 |
| EU/1/10/664 | Pumarix | Liechtenstein | 28.2.2015 |
| EU/1/10/664 | Pumarix | Norway | 31.1.2015 |
| EU/1/11/686 | Rasilamlo | Liechtenstein | 30.6.2015 |
| EU/1/11/723 | Pioglitazone Krka | Norway | 21.1.2015 |
| EU/1/11/748 | Docetaxel Mylan (Sunset clause) | Norway | 3.2.2015 |
| EU/1/12/754 | Sepioglin | Liechtenstein | 28.2.2015 |
| EU/1/12/774 | Rienso | Iceland | 12.5.2015 |
| EU/1/12/774 | Rienso | Liechtenstein | 30.4.2015 |
| EU/1/12/774 | Rienso | Norway | 19.5.2015 |
| EU/1/12/804 | BindRen | Iceland | 13.3.2015 |
| EU/1/12/804 | BindRen | Liechtenstein | 30.4.2015 |
| EU/1/12/804 | BindRen | Norway | 14.4.2015 |
| EU/1/13/867 | Provenge | Liechtenstein | 30.6.2015 |
| EU/1/13/867 | Provenge | Norway | 15.6.2015 |
| EU/1/97/037 | Vistide | Norway | 4.2.2015 |
| EU/2/04/049 | Purevax RCCh | Iceland | 10.2.2015 |
| EU/2/07/071 | Slentrol | Iceland | 5.2.2015 |
| EU/2/07/071 | Slentrol | Liechtenstein | 28.2.2015 |
| EU/2/07/071 | Slentrol | Norway | 30.3.2015 |
| EU/2/11/136 | TruScient | Iceland | 5.2.2015 |
| EU/2/11/136 | TruScient | Liechtenstein | 28.2.2015 |
| EU/2/11/136 | TruScient | Norway | 22.4.2015 |

EU Number

Product

Country

Date of authorisation

EU/1/07/426

Olanzapine Cipla

Norway

21.1.2015

EU/1/08/458

Trevaclyn

Liechtenstein

28.2.2015

EU/1/08/459

Tredaptive

Liechtenstein

28.2.2015

EU/1/08/460

Pelzont

Liechtenstein

28.2.2015

EU/1/09/554

Clopidogrel ratiopharm

Liechtenstein

28.2.2015

EU/1/09/560

Clopidogrel Dura

Liechtenstein

30.6.2015

EU/1/09/560

Clopidogrel Dura

Norway

30.6.2015

EU/1/10/649

Clopidogrel Teva Pharma B.V.

Norway

21.1.2015

EU/1/10/650

Clopidogrel Teva Generics B.V.

Iceland

5.2.2015

EU/1/10/664

Pumarix

Iceland

20.2.2015

EU/1/10/664

Pumarix

Liechtenstein

28.2.2015

EU/1/10/664

Pumarix

Norway

31.1.2015

EU/1/11/686

Rasilamlo

Liechtenstein

30.6.2015

EU/1/11/723

Pioglitazone Krka

Norway

21.1.2015

EU/1/11/748

Docetaxel Mylan (Sunset clause)

Norway

3.2.2015

EU/1/12/754

Sepioglin

Liechtenstein

28.2.2015

EU/1/12/774

Rienso

Iceland

12.5.2015

EU/1/12/774

Rienso

Liechtenstein

30.4.2015

EU/1/12/774

Rienso

Norway

19.5.2015

EU/1/12/804

BindRen

Iceland

13.3.2015

EU/1/12/804

BindRen

Liechtenstein

30.4.2015

EU/1/12/804

BindRen

Norway

14.4.2015

EU/1/13/867

Provenge

Liechtenstein

30.6.2015

EU/1/13/867

Provenge

Norway

15.6.2015

EU/1/97/037

Vistide

Norway

4.2.2015

EU/2/04/049

Purevax RCCh

Iceland

10.2.2015

EU/2/07/071

Slentrol

Iceland

5.2.2015

EU/2/07/071

Slentrol

Liechtenstein

28.2.2015

EU/2/07/071

Slentrol

Norway

30.3.2015

EU/2/11/136

TruScient

Iceland

5.2.2015

EU/2/11/136

TruScient

Liechtenstein

28.2.2015

EU/2/11/136

TruScient

Norway

22.4.2015

---

ANNEX V

List of suspended marketing authorisations

The following marketing authorisations have been suspended in the EEA EFTA States during the period 1 January-30 June 2015:

| EU Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/13/847/001 | MACI | Norway | 22.1.2015 |

EU Number

Product

Country

Date of authorisation

EU/1/13/847/001

MACI

Norway

22.1.2015

---